Literature DB >> 24497357

TLC immunostaining for detection of "antiphospholipid" antibodies.

Fabrizio Conti1, Cristiano Alessandri, Francesca Romana Spinelli, Antonella Capozzi, Francesco Martinelli, Serena Recalchi, Roberta Misasi, Guido Valesini, Maurizio Sorice.   

Abstract

Thin-layer chromatography (TLC) is a nonquantitative technique, which has been employed in the detection of antiphospholipid (aPL) antibodies. Antiphospholipid syndrome (APS) is the most frequently acquired thrombophilia, characterized by thrombosis and obstetric manifestations associated to an autoimmune trait, represented by the positivity of antiphospholipid (aPL) antibodies. Immunoassays for anticardiolipin (aCL) and anti-β2 glycoprotein I (aβ2GPI) antibodies and clotting tests for lupus anticoagulant (LA) represent the standard tests for the routine detection of aPL. The term "seronegative APS" has been used to describe patients with clinical manifestation of APS and persistently negative aPL assessed with routine assays. TLC immunostaining is a useful method for the detection of different antigenic targets of "antiphospholipid" antibodies; it is able to identify the reactivity of serum aPL experimented with purified phospholipid molecules with a different exposure compared to ELISA methods. This method seems to be applicable in patients who repeatedly tested negative for the standard aPL, i.e., aCL, aβ2GPI, and LA. Therefore, this technique may be proposed as a second step test for the diagnosis of APS.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24497357     DOI: 10.1007/978-1-4939-0326-9_8

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  8 in total

Review 1.  Diagnosing antiphospholipid syndrome: 'extra-criteria' manifestations and technical advances.

Authors:  Savino Sciascia; Mary-Carmen Amigo; Dario Roccatello; Munther Khamashta
Journal:  Nat Rev Rheumatol       Date:  2017-08-03       Impact factor: 20.543

Review 2.  "New" antigenic targets and methodological approaches for refining laboratory diagnosis of antiphospholipid syndrome.

Authors:  Roberta Misasi; Antonella Capozzi; Agostina Longo; Serena Recalchi; Emanuela Lococo; Cristiano Alessandri; Fabrizio Conti; Guido Valesini; Maurizio Sorice
Journal:  J Immunol Res       Date:  2015-03-19       Impact factor: 4.818

3.  A Monocentric Cohort of Obstetric Seronegative Anti-Phospholipid Syndrome.

Authors:  Simona Truglia; Antonella Capozzi; Silvia Mancuso; Serena Recalchi; Francesca Romana Spinelli; Carlo Perricone; Caterina De Carolis; Valeria Manganelli; Gloria Riitano; Tina Garofalo; Agostina Longo; Sara De Carolis; Cristiano Alessandri; Roberta Misasi; Guido Valesini; Maurizio Sorice; Fabrizio Conti
Journal:  Front Immunol       Date:  2018-07-20       Impact factor: 7.561

Review 4.  Molecular Mechanisms of "Antiphospholipid Antibodies" and Their Paradoxical Role in the Pathogenesis of "Seronegative APS".

Authors:  Roberta Misasi; Agostina Longo; Serena Recalchi; Daniela Caissutti; Gloria Riitano; Valeria Manganelli; Tina Garofalo; Maurizio Sorice; Antonella Capozzi
Journal:  Int J Mol Sci       Date:  2020-11-09       Impact factor: 5.923

5.  The Role of Cardiolipin as a Scaffold Mitochondrial Phospholipid in Autophagosome Formation: In Vitro Evidence.

Authors:  Valeria Manganelli; Antonella Capozzi; Serena Recalchi; Gloria Riitano; Vincenzo Mattei; Agostina Longo; Roberta Misasi; Tina Garofalo; Maurizio Sorice
Journal:  Biomolecules       Date:  2021-02-05

Review 6.  Current Promising Biomarkers and Methods in the Diagnostics of Antiphospholipid Syndrome: A Review.

Authors:  Pavla Bradacova; Ludek Slavik; Jana Ulehlova; Adela Skoumalova; Jana Ullrychova; Jana Prochazkova; Antonin Hlusi; Gayane Manukyan; Eva Kriegova
Journal:  Biomedicines       Date:  2021-02-08

7.  Determination of Thrombogenicity Levels of Various Antiphospholipid Antibodies by a Modified Thrombin Generation Assay in Patients with Suspected Antiphospholipid Syndrome.

Authors:  Pavla Bradáčová; Luděk Slavík; Adéla Skoumalová; Jana Úlehlová; Eva Kriegová; Gayane Manukyan; David Friedecký; Barbora Piskláková; Jana Ullrychová; Jana Procházková; Antonín Hluší
Journal:  Int J Mol Sci       Date:  2022-08-11       Impact factor: 6.208

8.  "Non-criteria" antiphospholipid antibodies add value to antiphospholipid syndrome diagnoses in a large Chinese cohort.

Authors:  Tingting Liu; Jieyu Gu; Liyan Wan; Qiongyi Hu; Jialin Teng; Honglei Liu; Xiaobing Cheng; Junna Ye; Yutong Su; Yue Sun; Jinfeng Zhou; Gary L Norman; Xuefeng Wang; Chengde Yang; Hui Shi
Journal:  Arthritis Res Ther       Date:  2020-02-21       Impact factor: 5.156

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.